D2G Oncology

Back To Portfolio D2G Oncology Website Headquarters: Palo Alto, CA Deal Team: Lou Lange Relating drugs to genotypes to transform precision cancer therapeutics. AMV AMV is a venture capital firm investing inearly-stage digital health, technology andlife sciences...

Biogen Idec

Back To Portfolio Biogen Idec FollowFollowFollowFollow Website Headquarters: Cambridge, MA Public: Nasdaq: BIIB, Nasdaq 100, S&P 500 Dedicated to developing new therapies to improve the lives of patients with neurological, autoimmune and hematological disorders...

Chimerix

Back To Portfolio Chimerix FollowFollow Website Headquarters: Durham, NC Public: Nasdaq: CMRX Deal Team: Skip Fleshman Developing and commercializing novel antiviral therapeutics in areas of high unmet medical need AMV AMV is a venture capital firm investing...

Esperion Therapeutics

Back To Portfolio Esperion Therapeutics FollowFollowFollowFollow Website Headquarters: Ann Arbor, MI Public: Nasdaq: ESPR Deal Team: Lou Lange Developer of HDL therapies to prevent, treat, and reverse cardiovascular and metabolic diseases AMV AMV is a venture capital...

ImmunoCellular Therapeutics

Back To Portfolio ImmunoCellular Therapeutics FollowFollow Website Public: Nasdaq: IMUC Headquarters: Calabasas, CA Deal Team: Lou Lange Developer of active immunotherapies to target regular tumor cells as well as cancer stem cells believed to cause cancer growth and...